BioWorld-International-2006-03-01

No Abstract

No Abstract

DUBLIN, Ireland - AGI Therapeutics plc, a specialty pharma company established by former Elan Corp. plc executives, raised gross proceeds of €42.5 million ($50.3 million) in an initial public offering Monday on the Irish Stock Exchange in Dublin and the Alternative Investment Market in London. (BioWorld International)

No Abstract

No Abstract

No Abstract